Monlunabant: Effective but with Side Effects Monlunabant, a weight loss drug used for chronic weight management and metabolic disorders, has shown promising results in clinical trials but comes with notable side effects
As a bonus, these foods are good for you and can improve other measures of health, such as lowering your risk for heart disease and cancer
Ongoing support : You will have continuous access to healthcare providers to monitor your progress and make any necessary adjustments to your treatment plan
Weight regain is common after discontinuing GLP-1 medications
Each batch is analyzed to ensure consistent quality
Its being studied for more (addiction, mental health, Alzheimers) Prices are coming down (Zepbound is 20% less expensive than Wegovy) But, on the other hand: Medicare is legally prevented from covering GLP1s for obesity Only 16 states cover anti-obesity medications under Medicaid 50% or less commercial plans cover GLP1s for obesity, and those that do often have unreasonable hurdles Covered can still mean $500-1000 out of pocket every month
:max_bytes(150000):strip_icc()/Health-GettyImages-1413029048-1570d2105e4840479118ceddf6c46e19.jpg)
